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Background. Recent studies confirmed cardioprotective role of intravenous magnesium for the prevention of cardiac events, but
effect of dietary intake of this mineral via recommended dietary regimens on control and inhibition of coronary artery disease
(CAD) risk factors has been questioned. The aim of the present study was to determine effect of Mediterranean dietary approach
on serum magnesium concentration among Iranian patients with CAD. Method. Baseline characteristics and clinical data of 102
consecutive patients with the diagnosis of CAD and candidates for isolated coronary artery bypass surgery were entered into the
study. Laboratory parameters especially serum magnesium concentration were measured after 12–14 h of overnight fasting and
before operation. Nutritional status was assessed by food frequency questionnaire and the diet score was calculated on the basis of
Mediterranean diet quality index (Med-DQI). Results. No significant differences were found in the concentrations of albumin, last
fasting blood sugar, last creatinine, and lipid profiles between the groups with Mediterranean dietary score < 5 and the group with
higher dietary score; however, serum magnesium concentration in the first group was higher than that in the group with higher
dietary score. Linear multivariate regression analysis showed that the lower Mediterranean dietary score was a predictor for serum
magnesium concentration after adjusting for confounders. Conclusion. Taking Mediterranean dietary regimen can be associated
with increased level of serum magnesium concentration, and thus this regimen can be cardioprotective because of its effects on
serum magnesium.
1. Introduction
The dietary magnesium intake tends to be lower than that
recommended worldwide even in western countries. Several
factors have been identified to be trigger for loweringmagne-
sium intake including the waterborne magnesium factor, the
loss of magnesium during food refining, and the magnesium
content of vegetarian diets, as well as various metabolic
situations such as hypertension, pregnancy, osteoporosis,
drug therapy, alcoholism, stress, and even cardiac trauma.
Magnesium is themost abundant intracellular divalent cation
that is important for physiological processes including neuro-
muscular function and maintenance of cardiovascular tone.
The importance of magnesium intake in relation to car-
diovascular diseases has been increasingly described, so that
its intake can be inversely related to the risk of hypertension
and type 2 diabetes mellitus [1] and may improve serum
lipid profiles [2]. Recent surveys in Sweden [3, 4] have
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Table 1: Construction of the score for the Mediterranean dietary
quality index (lower score indicates higher quality of regimen).
Scoring 0 1 2
Saturated fatty acids, % energy <10 10–13 >13
Cholesterol, mg <300 300–400 >400
Meats, g <25 25–125 >125
Olive oil, mL >15 15–5 <5
Fish, g >60 60–30 <30
Cereals, g >300 300–100 <100
Vegetables + fruits, g >700 700–400 <400
indicated that vegetarian diets provide a more adequate
intake of magnesium, as illustrated in Table 4. Note that
the magnesium intake of men and women on vegetarian
diets was considerably greater than the RDA requirement;
this was attributed to the high intake of vegetables and
whole-grain cereals by these individuals. Recent studies have
shown that some components of the Mediterranean diet
such as vegetables, legumes, and nuts are rich sources of
magnesium; therefore, it seems that the high adherence to
the Mediterranean diet is associated with high consumption
of magnesium [5]. Although the main dietary regimen of
Iranian population is Mediterranean diet components espe-
cially the major sources of magnesium, the rate of coronary
artery disease (CAD) risk factors among this population has
been considerably high [6].Therefore, in the present study,we
tried to determine effect of Mediterranean dietary approach
on laboratory parameters related to CAD risk factors with
the focus on serummagnesium concentration among Iranian
patients with CAD.
2. Methods
2.1. Study Population. Baseline characteristics and clinical
data of 102 consecutive patients with the diagnosis of CAD
and candidates for isolated coronary artery bypass surgery
were entered into the study. Studied data were collected by
the review of clinical recorded files in the day of admission.
In this study, CAD was considered significant if there was a
75% or greater stenosis in the cross-sectional diameter and
50% or greater stenosis in the luminal view [7].
2.2. Laboratory Measurements. Blood samples were drawn
from the corresponding peripheral vein into vacutainer
tubes after 12–14 h of overnight fasting and before operation.
Plasma glucose concentrations were assessed by means of
a glucose hexokinase method (Pars Azmoon kits accredited
by Bioactiva Diagnostica, Germany). Serum total cholesterol,
HDL cholesterol, and triglycerides were measured via enzy-
matic techniques (Pars Azmoon kits accredited by Bioacti-
vaDiagnostica, Germany). The Friedewald formula was used
to calculate low density lipoprotein (LDL) cholesterol, except
when the triglyceride level was>4.52mmol/L. Blood pressure
was calculated as the mean of two measurements, performed
Table 2: Demographic characteristics and clinical data of studied
patients (𝑛 = 102).
Male gender 41 (40.2)
Age (year) 58.86 ± 8.90
Body mass index (kg/m2) 32.57 ± 2.46
Family history of CAD 53 (52.0)
Current cigarette smoking 30 (29.4)
Opium addiction 9 (8.8)
Diabetes mellitus
Hyperlipidemia 77 (75.5)
Hypertension 58 (56.9)
Cerebrovascular disease 7 (6.9)
Peripheral vascular disease 35 (34.3)
Recent myocardial infarction 49 (48.0)
Renal failure 11 (10.8)
Ejection fraction (%) 50.00 ± 9.59
Functional class:
I 26 (25.5)
II 51 (50.0)
III 25 (24.5)
Euroscore 2.25 ± 2.06
Coronary vessels involvement:
Single-vessel disease 3 (3.0)
Two-vessel disease 24 (23.5)
Three-vessel disease 75 (73.5)
CAD: coronary artery disease.
in the sitting position after 5 minutes of rest, using a random-
zero sphygmomanometer (Hawksley-Gelman, Lancing, Sus-
sex, UK). C-reactive protein (CRP) level was measured by
immunoturbidimetry (Pars Azmun, Iran), and lipoprotein(a)
was measured using Tint ELIZA (Biopool, USA). Creatinine
was measured with Jaffe reaction (Parsazmon Kit, Tehran,
Iran) using an autoanalyzer (Hitachi, Tokyo, Japan). Serum
magnesium level was measured calorimetrically by an auto-
analyzer.
2.3. Mediterranean Diet. Studied patients were also inter-
viewed on admission to surgical ward and before operation
to report the consumption of food items listed as the number
of times per day, per month, or per year during the previous
year. We assessed nutritional status by a validated food
frequency questionnaire (FFQ), previously validated in Iran
[8] and a 24-hour dietary recall questionnaire to record the
types, amounts, and frequencies of foods consumed. Sum
of the consumption of each of several food items was used
to determine the overall consumption of the food group
to which each item belonged [9, 10]. The diet score was
calculated on the basis of Mediterranean diet quality index
(Med-DQI) that the construction of the score for this Index
(Table 1). The index assigns a score of 0, 1, or 2 according to
the daily intake of each of the seven components and then
final score was reported as a summation of all nutrient scores
ranged between 0 and 14.A lower score on this index indicates
a better nutrition quality [11]. We divided studied patients
Journal of Nutrition and Metabolism 3
Table 3: Laboratory parameters in the groups with the dietary score lower than 5 and group with higher dietary score.
Laboratory parameters Dietary score lower than 5 (𝑛 = 35) Dietary score between 5 and 10 (𝑛 = 67) 𝑃 value
Magnesium 2.01 ± 0.40 1.80 ± 0.28 0.026
Last fasting blood sugar (mg/dL) 111.38 ± 30.25 109.43 ± 31.83 0.763
Last creatinine (mg/dL) 1.21 ± 0.28 1.25 ± 0.24 0.498
Hematocrit 41.18 ± 4.02 41.75 ± 4.34 0.510
Triglyceride (mg/dL) 175.92 ± 58.09 178.49 ± 94.67 0.866
Cholesterol (mg/dL) 168.24 ± 43.73 161.14 ± 42.49 0.435
High density lipoprotein (mg/dL) 41.64 ± 9.29 40.43 ± 8.62 0.525
Low density lipoprotein (mg/dL) 89.94 ± 37.19 85.79 ± 33.98 0.584
Lipoprotein (a) (mg/dL) 36.00 ± 28.25 27.92 ± 27.46 0.172
Albumin (g/dL) 4.65 ± 0.26 4.65 ± 0.27 0.918
C-reactive protein 6.33 ± 1.70 6.31 ± 4.58 0.974
Table 4: Multivariate analysis for determining the effects of Mediterranean dietary score on serum magnesium concentration adjusted for
baseline variables as confounders.
Variables Univariate 𝑃 value Multivariate 𝑃 value Multivariate analysis
Standardized beta 95% CI for beta
Mediterranean dietary score 0.026 0.022 −0.289 −0.032–0.399
Male gender 0.037 0.116 0.207 −0.039–0.345
Number of defected coronary vessels 0.044 0.944 −0.009 −0.181–0.169
Body mass index 0.065 0.165 −0.193 −0.078–0.014
C-reactive protein 0.071 0.027 0.280 0.006–0.096
Low density lipoprotein 0.021 0.031 0.276 0.000–0.005
into two groups according to the final score: the groups with
final score lower than 5 (𝑛 = 35) and those who had final
score between 5 and 10 (𝑛 = 67). None of the patients had
final score more than 10.
2.4. Statistical Analysis. We compared categorized variables
between the two above groups using Chi-square test or
Fisher’s exact test if required. Continuous variables were
also compared using independent t-test. Multivariate linear
regression analysis was used to investigate the potential con-
founding effects of patients’ characteristics and clinical data
on the association between serummagnesium concentration
and Mediterranean regimen score. 𝑃 values of 0.05 or less
were considered statistically significant. All the statistical
analyses were performed using SPSS version 13.0 (SPSS Inc.,
Chicago, IL, USA).
3. Results
Studied patients had the mean age of 58.8 year (ranged
between 38 and 78 years) and 40.2% of them were male.
Hyperlipidemia and hypertension were observed in 75.5%
and 56.9% of patients, respectively, and 51.0% of them
were diabetics. Half of the studied patients had moderate
functional class, but three coronary arteries were involved
in the majority of them (Table 2). Comparison of the con-
centrations of serum laboratory parameters between the two
groups with lower Mediterranean dietary score and group
with higher dietary score showed no significant differences
between the concentration of albumin, last fasting blood
sugar, last creatinine, and lipid profiles (Table 3); however,
serum magnesium concentration in the group with dietary
score between 5 and 10 was lower than that in group with
higher score (𝑃 = 0.026). Linear multivariate regression
analysis also showed that the lower Mediterranean dietary
score was a predictor for serum magnesium concentration
after adjusting for confounders (Table 4).
4. Discussion
Recent studies could confirm the cardioprotective role of
intravenous magnesium for prevention of cardiac arrhyth-
mia, pump dysfunction, and death in patients with CAD,
especially in the immediate postinfarction period [12, 13].The
mechanism of this role has been also described. Magnesium
can inhibit the influx of calcium in vascular smooth muscle
cells and therefore inhibit arrhythmic recurrence and the
production of IL-6 andMMP-1 after reperfusion and prevent
the increase ofmyocardial lesions caused by calciumoverload
on myocytes [14]. However, effect of dietary intake of this
mineral on control and inhibition of CAD risk factors has
been questioned. Some researchers have been hypnotized
that the low intake of magnesium may be related to the least
degree of cardiovascular disease [15, 16]. Some others could
show that the dietary magnesium intake can be inversely
associated with fasting serum insulin, plasma high density
lipoprotein-cholesterol, and systolic and diastolic blood pres-
sure [17].
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In the present study, we showed the potential effect
of Mediterranean dietary regimen on increasing of serum
magnesium concentration that canmainly lead to the favorite
control and prevention of CAD risk factors. We have shown
that not only intravenous magnesium administration can
be related to the lower risk of poor outcome in patients
with CAD, but also these effects can be obtained by dietary
intake of this mineral via Mediterranean dietary regimen.
In a similar study by Schro¨der, it was found that the high
consumption of vegetables, fruits, legumes, nuts, fish, cereals,
and olive oil as main components of Mediterranean regimen
led to high absorption of magnesiumin obesity and type 2
diabetes [18]. Also, Singh showed that the increased intake
of dietary magnesium in association with the general effects
of a nutritious diet can offer protection against cardiovascular
deaths among high-risk individuals predisposed to CAD [19].
Furthermore, in another study, it was observed that the intake
of dietary magnesium was associated with a reduced risk
of CAD; however, associations between dietary magnesium
and coronary events occurring after fifteen years of follow-
up were modest [20]. It seems that theMediterranean dietary
regimen and its components as rich pools of magnesium-
might optimize micronutrient status in main body organs
especially cardiovascular system [21].
In the present study, it was also found that the patients’
baseline characteristics and even severity of CAD had no
relationship with serum magnesium concentration in multi-
variate analysis. Similarly, in a study by Mataix et al., the risk
of hypomagnesemia was not associated with any of the other
factors that were investigated such as gender, educational
level, obesity, smoking habits, alcohol consumption, and
physical exercise [22]. However, some studies showed that
the magnesium intake could decrease in advanced age and
in men for each of the different race or ethnic groups [23].
It seems that the serum magnesium changes are mainly
dependant on nutritional habit, metabolicprocesses, inflam-
matory biomarkers, and other related-potential mechanisms
that should be investigated in future studies.
In conclusion, taking Mediterranean dietary regimen
can be associated with increased level of serum magnesium
concentration, and thus this regimen can be cardioprotective
because of its effects on serum magnesium.
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